TitleLeading InstitutePrincipal InvestigatorNumber of Participating CentersNumber of CasesResearch Status
Not yet recruitedRecruiting in progressDuring follow-upAt the end of the question
Study on Huaier Granules in Unresectable Hepatocellular Carcinoma at Stage III According to the CNLC Staging System
Multicenter, Registry Study to Observe the Efficacy and Safety of Different Treatment Regimens for Unresectable Hepatocellular Carcinoma at Stage III According to the CNLC Staging System
Zhongshan Hospital, Fudan University Fan Jia 22 750
Study on Huaier Granules Versus Capecitabine Monotherapy in Preventing Recurrence and Metastasis after Radical Surgery for Stage II Colorectal Cancer
Prospective, Multicenter, Randomized, Parallel-Controlled Study on Huaier Granules Versus Capecitabine Monotherapy in Preventing Recurrence and Metastasis after Radical Surgery for Stage II Colorectal Cancer
Fudan University Shanghai Cancer Center Cai Sanjun 23 756
Clinical Study on Prednisone Combined with Huaiqihuang Granules in the Treatment of Nephrotic Syndrome in Children
Prospective, Multicenter, Randomized, Double-Blind, Double-Dummy, Non-Inferiority Parallel-Controlled Clinical Trial to Compare the Efficacy and Safety of Prednisone Combined with Huaiqihuang Granules Versus Prednisone Combined with Levamisole in the Treatment of Nephrotic Syndrome in Children
Tongji Hospital of Tongji Medical College of HUST Zhou Jianhua 25 402
Study on Huaiqihuang (HQH) Granules in the Treatment of Primary Glomerulonephritis at Stage 3 CKD
Randomized, Double-Blind, Double-Dummy, Positive Parallel-Controlled Multicenter Clinical Study on Huaiqihuang (HQH) Granules in the Treatment of Primary Glomerulonephritis at Stage 3 CKD
The First Affiliated Hospital of Dalian Medical University Lin Hongli 35 466
Study on Huaier Granules in the Treatment of Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy
Multicenter, Randomized, Open, Parallel-Controlled Clinical Study on Huaier Granules in the Treatment of Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy
Chinese PLA General Hospital Chen Xiangmei 30 480
Observational Study on Huaier Granules in Patients with Advanced Breast Cancer without Visceral Metastasis
Multicenter, Open, Randomized Controlled, Prospective Clinical Study on Huaier Granules in Patients with Advanced Breast Cancer without Visceral Metastasis
Fudan University Shanghai Cancer Center Shao Zhimin 8 398
Study on Huaier Granules Combined with Capecitabine in Patients with Unresectable Pancreatic Cancer
Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Study on the Efficacy and Safety of Huaier Granules Combined with Capecitabine versus Capecitabine Monotherapy in Patients with Unresectable Pancreatic Cancer
The First Affiliated Hospital of Xi'an Jiaotong University Wang Zheng 34 488
Study on Huaier Granules as Adjuvant Therapy for Resectable Pancreatic Cancer after Surgery
Observational Study on the Efficacy of Huaier Granules as Adjuvant Therapy for Resectable Pancreatic Cancer after Surgery
The First Affiliated Hospital of Xi'an Jiaotong University Wang Zheng 34 642
Study on Huaier Granules in Preventing Recurrence after Radical Surgery for Stage II-III Gastric Cancer
Multicenter, Prospective, Open-Label, Randomized Controlled Study on the Efficacy and Safety of Huaier Granules Compared with SOX Regimen in Preventing Recurrence/Metastasis after Radical Surgery for Stage II-III Gastric Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Tao Kaixiong 17 702
Study on Huaier Granules as Adjuvant Therapy for Resectable Stage II-IIIA Non-Small Cell Lung Cancer after Surgery
Observational Study on the Efficacy and Safety of Huaier Granules Compared with Platinum-Based Doublet Chemotherapy as Adjuvant Therapy for Resectable Stage II-IIIA Non-Small Cell Lung Cancer after Surgery
Liaoning Cancer Hospital & Institute Liu Hongxu 16 240
Study on Huaier Granules as Adjuvant Therapy for Triple-Negative Breast Cancer after Surgery
Prospective, Multicenter, Randomized, Controlled, Open-Label Study on Huaier Granules as Adjuvant Therapy for High-Risk Triple-Negative Invasive Ductal Carcinoma after Surgery
Fudan University Shanghai Cancer Center Shao Zhimin 38 1072